Related Experiment Video

Updated: Jan 27, 2026

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
08:56

A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues

Published on: December 5, 2016

11.3K

RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3

Yi Niu1, Ziyou Lin1, Arabella Wan2

  • 1School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou, 510006, China.

Molecular Cancer
|March 30, 2019
PubMed
Abstract

Insights

The study reveals that the FTO enzyme, a key regulator of N6-methyladenosine (m6A) modification, is elevated in breast cancer and promotes tumor growth. Targeting FTO may offer a new therapeutic strategy for breast cancer patients.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Oncology

Background:

  • N6-methyladenosine (m6A) is a prevalent mRNA modification regulating gene expression.
  • The role of m6A modification in breast cancer pathogenesis remains incompletely understood.

Purpose of the Study:

  • To investigate the role of m6A modification, specifically the FTO-BNIP3 axis, in breast cancer.
  • To identify potential therapeutic targets for breast cancer based on m6A regulation.

Main Methods:

  • m6A-RNA immunoprecipitation sequencing was employed to identify m6A targets in breast cancer.
  • In vitro and in vivo assays were conducted in breast cancer cell lines and patient tissues to elucidate the FTO-BNIP3 mechanism.

Main Results:

  • FTO, an m6A demethylase, is upregulated in breast cancer and associated with poor patient survival.
  • FTO promotes breast cancer cell proliferation, colony formation, and metastasis.
  • FTO targets BNIP3, a tumor suppressor gene, leading to its degradation and promoting tumor growth.

Conclusions:

  • FTO plays a significant role in breast cancer progression through m6A modification of BNIP3.
  • FTO represents a potential novel therapeutic target for breast cancer treatment.
Keywords:
ApoptosisBNIP3Breast cancerFTON6-methyladenosine

More Related Videos

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer07:45

Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer

Published on: May 18, 2020

6.9K
Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis10:56

Dual Bioluminescence Imaging of Tumor Progression and Angiogenesis

Published on: August 1, 2019

8.8K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
18.7K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.0K
RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
10.8K
Bacterial RNA Polymerase00:43

Bacterial RNA Polymerase

Unlike eukaryotes, bacteria use a single RNA Polymerase (RNAP) to transcribe all genes. The different subunits of bacterial RNAPhave distinct functions. The multisubunit structure of the bacterial RNAP helps the enzyme to maintain catalytic function, facilitate assembly, interact with DNA and RNA, and self-regulate its activity.
In most genes, the transcription site is a single base present upstream of the coding sequence. Though RNAP is a catalytically efficient enzyme, it does not recognize...
32.6K
Eukaryotic RNA Polymerases00:58

Eukaryotic RNA Polymerases

RNA Polymerase (RNAP) is conserved in all animals, with bacterial, archaeal, and eukaryotic RNAPs sharing significant sequence, structural, and functional similarities. Among the three eukaryotic RNAPs, RNA Polymerase II is most similar to bacterial RNAP in terms of both structural organization and folding topologies of the enzyme subunits. However, these similarities are not reflected in their mechanism of action.
All three eukaryotic RNAPs require specific transcription factors, of which the...
26.8K